 |
05.21.2013
Ironwood Pharmaceuticals Prices Public Offering of Common Stock
|
18.1 KB |
| |
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the pricing of
an underwritten public offering of 10,500,000 shares of its Class A
common stock at a price of $13.00 per share to the public. All of the
shares are being offered by Ironwood. The gross procee...
|
 |
05.20.2013
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
|
16.8 KB |
| |
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it has
commenced an underwritten public offering of 10,500,000 shares of its
Class A common stock. All of the shares are being offered by Ironwood.
The Company will grant the underwriters a 30-day optio...
|
 |
05.14.2013
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013
|
159.4 KB |
| |
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest
Laboratories, Inc. (NYSE: FRX) announced today they will present
linaclotide-related data during Digestive Disease Week® 2013 in Orlando,
Fla., May 18 through May 21, 2013. Among the data highligh...
|
 |
05.07.2013
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Health Care Conference
|
14.9 KB |
| |
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update
at the Bank of America Merrill Lynch 2013 Health Care Conference on
Tuesday, May 14, 2013 at 5:00 p.m. Pacific Time / 8:00 p.m. Eastern Time
at the Encore at the Wynn in Las Vegas.
...
|
 |
04.23.2013
Ironwood Pharmaceuticals Provides First Quarter 2013 Investor Update
|
168.5 KB |
| |
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its
first quarter 2013 and recent business activities.
"We and Forest have made significant process advancing LINZESS during
the first few months of commercialization, and the pos...
|
|
|